CINACALCET

CINACALCET was reported 46376 times

CINACALCET is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHOSPHATURIC MESENCHYMAL TUMOUR 4 0.3636
1 BROWN TUMOUR 17 0.3400
2 PARATHYROID HYPERPLASIA 19 0.3393
3 HYPERPARATHYROIDISM TERTIARY 25 0.3333
4 PARATHYROID TUMOUR MALIGNANT 42 0.3281
5 PARATHYROID HAEMORRHAGE 4 0.2500
6 PARATHYROID HORMONE-RELATED PROTEIN INCREASED 5 0.2273
7 PSEUDOFRACTURE 4 0.2105
8 LARYNGEAL NERVE DYSFUNCTION 3 0.1765
9 HIGH TURNOVER OSTEOPATHY 9 0.1525
10 PARATHYROID TUMOUR BENIGN 104 0.1402
11 NEONATAL HYPOCALCAEMIA 10 0.1333
12 ADJUSTED CALCIUM INCREASED 6 0.1132
13 NEONATAL CHOLESTASIS 7 0.0833
14 CALCIPHYLAXIS 141 0.0768
15 MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA 4 0.0741
16 HYPOCALCIURIA 4 0.0714
17 PARATHYROID GLAND ENLARGEMENT 10 0.0699
18 HYPOCALCAEMIC SEIZURE 5 0.0667
19 BLOOD 1,25-DIHYDROXYCHOLECALCIFEROL INCREASED 6 0.0652
20 PELVIC DEFORMITY 8 0.0620
21 ONCOCYTOMA 3 0.0600
22 CALCIFICATION METASTATIC 4 0.0444
23 HYPERPARATHYROIDISM PRIMARY 16 0.0440
24 ARTERIOVENOUS FISTULA SITE COMPLICATION 26 0.0433
25 CRYSTAL DEPOSIT INTESTINE 8 0.0372
26 COMPUTERISED TOMOGRAM HEART ABNORMAL 3 0.0366
27 SHUNT STENOSIS 10 0.0361
28 ANGIODERMATITIS 3 0.0353
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 37 0.0348
30 HYPERCALCAEMIA OF MALIGNANCY 9 0.0331
31 CALCINEURIN INHIBITOR INDUCED PAIN SYNDROME 3 0.0326
32 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 6 0.0321
33 ARTERIOVENOUS FISTULA THROMBOSIS 11 0.0318
34 SECONDARY HYPERTHYROIDISM 3 0.0309
35 BLOOD PARATHYROID HORMONE INCREASED 90 0.0309
36 PARATHYROID TUMOUR 8 0.0291
37 HYPERPARATHYROIDISM 59 0.0286
38 HYPERPARATHYROIDISM SECONDARY 66 0.0263
39 HYPOPARATHYROIDISM 20 0.0261
40 INCREASED DOSE ADMINISTERED 8 0.0256
41 MYOCARDIAL CALCIFICATION 3 0.0256
42 PNEUMONIA ADENOVIRAL 5 0.0253
43 PARATHYROIDECTOMY 11 0.0229
44 INTRACARDIAC MASS 4 0.0226
45 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 2 0.0220
46 NEPHROCALCINOSIS 26 0.0219
47 CUTANEOUS CALCIFICATION 4 0.0219
48 FOETAL HEART RATE DECELERATION ABNORMALITY 15 0.0212
49 ADJUSTED CALCIUM DECREASED 2 0.0189
50 ANGIOTENSIN CONVERTING ENZYME INCREASED 3 0.0183
51 HYPERCALCIURIA 9 0.0183
52 ABDOMINAL REBOUND TENDERNESS 2 0.0179
53 BLOOD PARATHYROID HORMONE DECREASED 26 0.0175
54 MULTISYSTEM INFLAMMATORY SYNDROME 3 0.0173
55 BENIGN PANCREATIC NEOPLASM 3 0.0158
56 SHUNT OCCLUSION 8 0.0157
57 HYPERCALCAEMIA 190 0.0154
58 HYPERPHOSPHATAEMIA 32 0.0149
59 PULMONARY CALCIFICATION 6 0.0145
60 HYPOCALCAEMIA 273 0.0144
61 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 4 0.0138
62 PARATHYROID DISORDER 11 0.0135
63 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 3 0.0126
64 INTRACRANIAL HAEMATOMA 7 0.0124
65 NONINFECTIOUS PERITONITIS 3 0.0123
66 GASTRIC MUCOSAL HYPERTROPHY 3 0.0121
67 RENAL TRANSPLANT FAILURE 12 0.0121
68 RENAL TUBULAR INJURY 14 0.0115
69 RENAL TRANSPLANT 41 0.0113
70 PLACENTAL INSUFFICIENCY 9 0.0112
71 MENINGOENCEPHALITIS HERPETIC 5 0.0112
72 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 9 0.0111
73 SKIN FIBROSIS 5 0.0103
74 CHRONIC ALLOGRAFT NEPHROPATHY 8 0.0102
75 DELAYED GRAFT FUNCTION 7 0.0098
76 HYPERINSULINAEMIA 3 0.0098
77 BLOOD PARATHYROID HORMONE ABNORMAL 6 0.0095
78 NEPHROGENIC ANAEMIA 41 0.0088
79 VASCULAR CALCIFICATION 9 0.0084
80 HYPEREMESIS GRAVIDARUM 3 0.0078
81 RENAL HAEMATOMA 4 0.0078
82 HYPERMAGNESAEMIA 5 0.0077
83 CALCINOSIS 17 0.0076
84 IRON OVERLOAD 8 0.0074
85 GASTROINTESTINAL ANGIODYSPLASIA 3 0.0073
86 OSTEOMALACIA 11 0.0071
87 PRECOCIOUS PUBERTY 4 0.0070
88 RETICULOCYTE COUNT DECREASED 3 0.0070
89 HAEMORRHAGIC OVARIAN CYST 4 0.0070
90 GRAFT COMPLICATION 4 0.0068
91 TORTICOLLIS 14 0.0066
92 INFECTED SKIN ULCER 12 0.0063
93 MITRAL VALVE CALCIFICATION 4 0.0062
94 COMPLICATIONS OF TRANSPLANTED KIDNEY 14 0.0062
95 TRANSPLANT DYSFUNCTION 11 0.0062
96 BLOOD CALCIUM INCREASED 53 0.0060
97 LANGUAGE DISORDER 13 0.0060
98 RENAL VEIN THROMBOSIS 4 0.0059
99 ALCOHOLIC LIVER DISEASE 2 0.0059
100 AORTIC VALVE CALCIFICATION 3 0.0058
101 ADENOMA BENIGN 5 0.0058
102 HUMAN CHORIONIC GONADOTROPIN INCREASED 5 0.0055
103 BLOOD CALCIUM ABNORMAL 9 0.0054
104 ASYMPTOMATIC COVID-19 2 0.0051
105 CRYSTAL NEPHROPATHY 3 0.0051
106 SUPERIOR VENA CAVA SYNDROME 3 0.0050
107 PORPHYRIA ACUTE 7 0.0049
108 END STAGE RENAL DISEASE 89 0.0049
109 VITAMIN D INCREASED 3 0.0049
110 PRODUCT MONITORING ERROR 7 0.0048
111 PERITONEAL DIALYSIS 4 0.0048
112 NORMOCYTIC ANAEMIA 7 0.0048
113 PAPILLARY THYROID CANCER 8 0.0046
114 HYPOMAGNESAEMIA 64 0.0046
115 LYMPHOCELE 3 0.0045
116 BONE DEFORMITY 3 0.0045
117 INFECTIOUS PERITONITIS 3 0.0044
118 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7 0.0044
119 CLEAR CELL RENAL CELL CARCINOMA 3 0.0043
120 NEPHROGENIC SYSTEMIC FIBROSIS 13 0.0043
121 AIR EMBOLISM 2 0.0042
122 JAUNDICE NEONATAL 8 0.0042
123 KIDNEY TRANSPLANT REJECTION 20 0.0042
124 AMNIOTIC CAVITY INFECTION 3 0.0041
125 POST PROCEDURAL HAEMATOMA 7 0.0041
126 VESTIBULAR DISORDER 5 0.0041
127 ARTERIOVENOUS FISTULA 2 0.0041
128 JUGULAR VEIN THROMBOSIS 7 0.0039
129 POLYHYDRAMNIOS 4 0.0039
130 BONE MARROW OEDEMA 4 0.0039
131 TUMOUR NECROSIS 4 0.0038
132 ALBUMINURIA 2 0.0037
133 PANCREATITIS RELAPSING 3 0.0037
134 BLOOD PHOSPHORUS INCREASED 10 0.0037
135 PERITONEAL CLOUDY EFFLUENT 5 0.0036
136 RENAL ARTERY STENOSIS 5 0.0036
137 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
138 HYPOPHOSPHATAEMIA 26 0.0035
139 KIDNEY FIBROSIS 6 0.0035
140 RENAL HAEMORRHAGE 7 0.0034
141 RESTRICTIVE PULMONARY DISEASE 4 0.0034
142 RENAL TUBULAR ATROPHY 3 0.0034
143 KYPHOSIS 6 0.0034
144 ADRENAL ADENOMA 2 0.0034
145 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 11 0.0033
146 ANAEMIA OF CHRONIC DISEASE 3 0.0033
147 TETANY 6 0.0033
148 DYSAESTHESIA 10 0.0033
149 HYPERVOLAEMIA 16 0.0032
150 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
151 PLACENTAL DISORDER 3 0.0032
152 PATHOLOGICAL FRACTURE 16 0.0031
153 BLOODY PERITONEAL EFFLUENT 3 0.0029
154 APLASIA PURE RED CELL 10 0.0029
155 SKIN INDURATION 6 0.0029
156 VITAMIN D DEFICIENCY 28 0.0029
157 URETEROLITHIASIS 3 0.0029
158 ESSENTIAL HYPERTENSION 5 0.0027
159 AORTIC ARTERIOSCLEROSIS 7 0.0027
160 PERITONITIS BACTERIAL 27 0.0027
161 LEG AMPUTATION 11 0.0027
162 METABOLIC ENCEPHALOPATHY 8 0.0027
163 HYPOPROTEINAEMIA 5 0.0026
164 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
165 FOLATE DEFICIENCY 3 0.0026
166 BILIRUBIN CONJUGATED INCREASED 6 0.0026
167 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 6 0.0026
168 RECTAL ULCER 3 0.0026
169 APLASIA 5 0.0026
170 PREMATURE DELIVERY 40 0.0025
171 EXPOSURE VIA BREAST MILK 10 0.0025
172 AZOTAEMIA 10 0.0025
173 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
174 PREMATURE RUPTURE OF MEMBRANES 6 0.0025
175 DEVICE RELATED SEPSIS 5 0.0025
176 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 10 0.0024
177 TRANSPLANT FAILURE 6 0.0024
178 STERNAL FRACTURE 3 0.0024
179 ADRENAL MASS 2 0.0024
180 RENAL ATROPHY 3 0.0024
181 LOW BIRTH WEIGHT BABY 19 0.0024
182 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
183 THORACIC VERTEBRAL FRACTURE 7 0.0024
184 ANAEMIA MACROCYTIC 5 0.0023
185 FIXED ERUPTION 4 0.0023
186 REBOUND ACID HYPERSECRETION 7 0.0023
187 ARTERIAL STENOSIS 2 0.0023
188 CEREBELLAR SYNDROME 5 0.0023
189 AORTIC VALVE STENOSIS 4 0.0022
190 POSTPARTUM HAEMORRHAGE 3 0.0022
191 CHRONIC GASTRITIS 5 0.0022
192 BLOOD PHOSPHORUS DECREASED 8 0.0022
193 VIRAEMIA 3 0.0022
194 THROMBOSIS IN DEVICE 7 0.0021
195 TRANSPLANT 5 0.0021
196 LACUNAR INFARCTION 5 0.0021
197 NODAL RHYTHM 3 0.0020
198 ACUTE ABDOMEN 3 0.0020
199 VENOUS THROMBOSIS 8 0.0020
200 SYSTEMIC CANDIDA 5 0.0020
201 GANGRENE 12 0.0020
202 ADHESION 3 0.0020
203 ULTRAFILTRATION FAILURE 4 0.0020
204 SUDDEN HEARING LOSS 4 0.0020
205 FUNGAL PERITONITIS 3 0.0020
206 INFECTIOUS PLEURAL EFFUSION 3 0.0020
207 CALCULUS URINARY 3 0.0019
208 DIVERTICULAR PERFORATION 4 0.0019
209 ATRIAL FLUTTER 15 0.0019
210 METABOLIC ALKALOSIS 3 0.0019
211 LEUKOCYTOCLASTIC VASCULITIS 3 0.0018
212 ACINETOBACTER INFECTION 2 0.0018
213 INTESTINAL ISCHAEMIA 10 0.0018
214 AORTIC DILATATION 2 0.0018
215 DRUG TOLERANCE DECREASED 5 0.0018
216 SKIN HYPERTROPHY 5 0.0018
217 BENIGN NEOPLASM 2 0.0018
218 ARTERIAL HAEMORRHAGE 2 0.0017
219 HYDRONEPHROSIS 13 0.0017
220 AORTIC STENOSIS 6 0.0017
221 HYPOVOLAEMIA 10 0.0017
222 PARAPARESIS 3 0.0017
223 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
224 X-RAY ABNORMAL 3 0.0017
225 HYPERKALAEMIA 58 0.0017
226 MYELOFIBROSIS 5 0.0017
227 SOFT TISSUE INFECTION 3 0.0016
228 DUODENITIS 5 0.0016
229 DIALYSIS 23 0.0016
230 PYELONEPHRITIS 14 0.0016
231 PERITONITIS 33 0.0016
232 SACROILIITIS 3 0.0016
233 LARGE INTESTINE PERFORATION 11 0.0016
234 URINARY TRACT INFECTION BACTERIAL 4 0.0016
235 FLUID OVERLOAD 23 0.0016
236 THERAPY NON-RESPONDER 71 0.0016
237 OSTEOPOROTIC FRACTURE 3 0.0016
238 ENDOCARDITIS 8 0.0016
239 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
240 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 45 0.0015
241 TORSADE DE POINTES 12 0.0015
242 PREMATURE BABY 46 0.0015
243 CATATONIA 8 0.0015
244 UNDERWEIGHT 3 0.0015
245 BLOOD LACTIC ACID INCREASED 8 0.0015
246 SERUM FERRITIN INCREASED 8 0.0015
247 MYOCLONUS 18 0.0015
248 GASTRITIS EROSIVE 7 0.0015
249 POTENTIATING DRUG INTERACTION 5 0.0015
250 BK VIRUS INFECTION 5 0.0015
251 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
252 PSYCHOTIC SYMPTOM 3 0.0015
253 BLOOD CALCIUM DECREASED 16 0.0014
254 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
255 BONE LESION 5 0.0014
256 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
257 TRANSPLANT REJECTION 11 0.0014
258 GASTROENTERITIS 20 0.0014
259 STRABISMUS 4 0.0014
260 CLOSTRIDIUM TEST POSITIVE 3 0.0014
261 PARADOXICAL DRUG REACTION 5 0.0014
262 PERIPHERAL VASCULAR DISORDER 7 0.0014
263 BACTERIAL TEST POSITIVE 3 0.0013
264 CATHETER SITE INFECTION 5 0.0013
265 FOETAL GROWTH RESTRICTION 8 0.0013
266 HAEMOGLOBIN INCREASED 6 0.0013
267 HAEMODIALYSIS 11 0.0013
268 ACIDOSIS 10 0.0013
269 THYROID MASS 5 0.0013
270 LOCALISED OEDEMA 6 0.0013
271 HYPOALBUMINAEMIA 10 0.0013
272 PELVIC FRACTURE 10 0.0013
273 FRACTURE 24 0.0013
274 CARDIOVASCULAR DISORDER 32 0.0013
275 ORTHOPNOEA 4 0.0013
276 PERITONEAL DIALYSIS COMPLICATION 9 0.0012
277 GLOMERULONEPHRITIS 3 0.0012
278 PERIPHERAL ISCHAEMIA 5 0.0012
279 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
280 CHRONIC KIDNEY DISEASE 92 0.0012
281 ILEUS 15 0.0012
282 HYPERNATRAEMIA 6 0.0012
283 ARTHROPOD STING 2 0.0012
284 CATHETER SITE HAEMORRHAGE 3 0.0012
285 SPINAL FRACTURE 24 0.0012
286 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
287 VENTRICULAR HYPERTROPHY 3 0.0012
288 OSTEITIS 3 0.0012
289 HALLUCINATIONS, MIXED 5 0.0012
290 RETINAL ARTERY OCCLUSION 3 0.0012
291 RENAL FAILURE CHRONIC 9 0.0012
292 CACHEXIA 6 0.0012
293 MALNUTRITION 13 0.0012
294 SKIN NECROSIS 6 0.0012
295 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
296 IMMUNOSUPPRESSION 10 0.0011
297 BONE EROSION 4 0.0011
298 ACUTE MYOCARDIAL INFARCTION 33 0.0011
299 STRESS FRACTURE 6 0.0011
300 LARGE INTESTINAL ULCER 3 0.0011
301 GASTRIC ULCER 21 0.0011
302 NORMAL NEWBORN 6 0.0011
303 SPONDYLITIS 4 0.0011
304 VENTRICULAR ARRHYTHMIA 4 0.0011
305 THERAPY PARTIAL RESPONDER 17 0.0011
306 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
307 GASTRIC ULCER HAEMORRHAGE 6 0.0011
308 HYPERTENSIVE CRISIS 12 0.0011
309 EXPOSURE DURING PREGNANCY 67 0.0011
310 ANGINA UNSTABLE 7 0.0011
311 NEPHROPATHY 10 0.0011
312 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
313 ANURIA 9 0.0010
314 DEVICE RELATED INFECTION 16 0.0010
315 THERAPEUTIC PRODUCT INEFFECTIVE 4 0.0010
316 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
317 GASTROINTESTINAL NECROSIS 3 0.0010
318 SPINAL CORD COMPRESSION 4 0.0010
319 NEPHROLITHIASIS 47 0.0010
320 RENAL TUBULAR NECROSIS 10 0.0010
321 GROWTH RETARDATION 3 0.0010
322 RESPIRATORY ACIDOSIS 4 0.0010
323 STAPHYLOCOCCAL SEPSIS 5 0.0010
324 RENAL CYST 8 0.0010
325 SMALL FOR DATES BABY 5 0.0010
326 GINGIVAL PAIN 8 0.0010
327 CEREBROVASCULAR DISORDER 3 0.0010
328 ACUTE KIDNEY INJURY 152 0.0010
329 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
330 HYPERURICAEMIA 4 0.0010
331 SPINAL COMPRESSION FRACTURE 8 0.0010
332 MYOCARDIAL ISCHAEMIA 11 0.0010
333 ACUTE CORONARY SYNDROME 8 0.0010
334 PERIORBITAL OEDEMA 5 0.0010
335 MALABSORPTION 5 0.0010
336 BONE DENSITY DECREASED 30 0.0010
337 ARTERIOSCLEROSIS 9 0.0010
338 BILE DUCT STONE 3 0.0009
339 AORTIC VALVE INCOMPETENCE 4 0.0009
340 COMPRESSION FRACTURE 5 0.0009
341 SINUS BRADYCARDIA 9 0.0009
342 ATAXIA 11 0.0009
343 OSTEOPENIA 14 0.0009
344 MATERNAL EXPOSURE DURING PREGNANCY 82 0.0009
345 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
346 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
347 DIVERTICULUM INTESTINAL 4 0.0009
348 HAEMOLYSIS 7 0.0009
349 SEPSIS 101 0.0009
350 CARDIAC FAILURE ACUTE 6 0.0009
351 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
352 ACUTE PULMONARY OEDEMA 5 0.0009
353 METASTASES TO LYMPH NODES 6 0.0009
354 SUDDEN CARDIAC DEATH 3 0.0009
355 BRONCHOPNEUMONIA 3 0.0009
356 ECCHYMOSIS 6 0.0009
357 NEUROLOGICAL SYMPTOM 5 0.0009
358 LEFT VENTRICULAR FAILURE 3 0.0009
359 UROSEPSIS 8 0.0009
360 GRANULOMA 3 0.0009
361 METASTASES TO LUNG 10 0.0009
362 TREATMENT NONCOMPLIANCE 47 0.0009
363 NEUROTOXICITY 15 0.0009
364 ESCHERICHIA INFECTION 7 0.0009
365 NECROTISING FASCIITIS 3 0.0009
366 VENTRICULAR TACHYCARDIA 14 0.0008
367 SARCOIDOSIS 4 0.0008
368 CARDIAC TAMPONADE 4 0.0008
369 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46 0.0008
370 MEDICATION RESIDUE PRESENT 4 0.0008
371 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
372 HYPOVOLAEMIC SHOCK 4 0.0008
373 VITAMIN D DECREASED 7 0.0008
374 AMYLASE INCREASED 3 0.0008
375 ACUTE PSYCHOSIS 2 0.0008
376 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
377 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
378 RENAL IMPAIRMENT 67 0.0008
379 CORONARY ARTERY STENOSIS 4 0.0008
380 APPENDICITIS PERFORATED 2 0.0008
381 ABDOMINAL INFECTION 2 0.0008
382 PHLEBITIS 4 0.0008
383 RIB FRACTURE 16 0.0008
384 ENCEPHALOPATHY 19 0.0008
385 FAILURE TO THRIVE 4 0.0008
386 BLOOD ALBUMIN DECREASED 6 0.0008
387 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
388 RENAL FAILURE 100 0.0008
389 FOETAL EXPOSURE DURING PREGNANCY 61 0.0007
390 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
391 ABDOMINAL RIGIDITY 2 0.0007
392 SHOCK HAEMORRHAGIC 6 0.0007
393 GOITRE 3 0.0007
394 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
395 ARTHRITIS BACTERIAL 3 0.0007
396 AORTIC DISSECTION 3 0.0007
397 GASTROINTESTINAL PERFORATION 3 0.0007
398 VENTRICULAR FIBRILLATION 8 0.0007
399 CONGESTIVE CARDIOMYOPATHY 3 0.0007
400 METABOLIC ACIDOSIS 23 0.0007
401 ASCITES 21 0.0007
402 ANGIOPATHY 4 0.0007
403 DUODENAL ULCER 5 0.0007
404 POOR PERIPHERAL CIRCULATION 3 0.0007
405 RECTAL HAEMORRHAGE 30 0.0007
406 ANGINA PECTORIS 20 0.0007
407 CARDIOGENIC SHOCK 10 0.0007
408 EXERCISE TOLERANCE DECREASED 4 0.0007
409 CARDIO-RESPIRATORY ARREST 29 0.0007
410 HORDEOLUM 3 0.0007
411 CHAPPED LIPS 3 0.0007
412 MELAENA 15 0.0007
413 ABDOMINAL ABSCESS 3 0.0007
414 PURPURA 6 0.0007
415 BLOOD POTASSIUM INCREASED 11 0.0007
416 CATHETERISATION CARDIAC 3 0.0007
417 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
418 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
419 PAPILLOEDEMA 3 0.0007
420 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
421 HAEMODYNAMIC INSTABILITY 5 0.0007
422 TENDON RUPTURE 8 0.0006
423 RENAL FUNCTION TEST ABNORMAL 3 0.0006
424 UMBILICAL HERNIA 3 0.0006
425 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
426 OSTEOPOROSIS 26 0.0006
427 PRE-ECLAMPSIA 3 0.0006
428 TRICUSPID VALVE INCOMPETENCE 5 0.0006
429 SCREAMING 4 0.0006
430 ACUTE RESPIRATORY FAILURE 12 0.0006
431 INTESTINAL PERFORATION 7 0.0006
432 DRUG RESISTANCE 16 0.0006
433 HAEMOGLOBIN ABNORMAL 4 0.0006
434 ENTEROCOCCAL INFECTION 3 0.0006
435 MITRAL VALVE INCOMPETENCE 7 0.0006
436 BACK DISORDER 10 0.0006
437 INCORRECT DOSAGE ADMINISTERED 3 0.0006
438 CHOLELITHIASIS 20 0.0006
439 METASTASES TO BONE 10 0.0006
440 OSTEOMYELITIS 11 0.0006
441 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
442 CORONAVIRUS INFECTION 4 0.0006
443 ELECTROLYTE IMBALANCE 7 0.0006
444 CYTOMEGALOVIRUS INFECTION 10 0.0006
445 ANXIETY DISORDER 2 0.0006
446 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
447 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
448 BLOOD UREA INCREASED 10 0.0006
449 CORONARY ARTERY DISEASE 18 0.0006
450 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
451 KLEBSIELLA INFECTION 3 0.0006
452 COLITIS ISCHAEMIC 4 0.0006
453 SKIN PLAQUE 5 0.0006
454 HOSPITALISATION 91 0.0006
455 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
456 NEUTROPHIL COUNT INCREASED 6 0.0006
457 POLYNEUROPATHY 7 0.0006
458 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
459 BLOOD CREATININE INCREASED 38 0.0006
460 SKIN HYPERPIGMENTATION 5 0.0006
461 CARDIAC ARREST 48 0.0006
462 UNRESPONSIVE TO STIMULI 15 0.0006
463 GASTROINTESTINAL DISORDER 52 0.0006
464 SKIN ULCER 15 0.0006
465 HYPERBILIRUBINAEMIA 6 0.0006
466 STAPHYLOCOCCAL INFECTION 19 0.0006
467 TONSILLITIS 3 0.0006
468 GASTRITIS 15 0.0006
469 SUDDEN DEATH 6 0.0006
470 LUNG INFILTRATION 5 0.0006
471 SINUS TACHYCARDIA 8 0.0006
472 METASTASIS 4 0.0006
473 HIP FRACTURE 18 0.0006
474 PRODUCT RESIDUE PRESENT 3 0.0006
475 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
476 ARRHYTHMIA 26 0.0005
477 CARDIAC FAILURE 44 0.0005
478 WOUND INFECTION 6 0.0005
479 MENTAL STATUS CHANGES 15 0.0005
480 TRANSAMINASES INCREASED 12 0.0005
481 HYPOXIA 19 0.0005
482 PANCYTOPENIA 30 0.0005
483 HYPOGLYCAEMIA 26 0.0005
484 ABORTION INDUCED 5 0.0005
485 REBOUND EFFECT 6 0.0005
486 PREMATURE LABOUR 3 0.0005
487 GASTROINTESTINAL HAEMORRHAGE 44 0.0005
488 HYPERTHERMIA 4 0.0005
489 PARANOIA 9 0.0005
490 BLOOD URIC ACID INCREASED 3 0.0005
491 PANCREATITIS 27 0.0005
492 DEATH 439 0.0005
493 SEPTIC SHOCK 22 0.0005
494 DIVERTICULITIS 14 0.0005
495 RENAL INJURY 15 0.0005
496 HYPERLIPIDAEMIA 6 0.0005
497 MUSCLE RIGIDITY 6 0.0005
498 HYPOTONIA 5 0.0005
499 RESTLESS LEGS SYNDROME 9 0.0005
500 HYPOTENSION 99 0.0005
501 SUBARACHNOID HAEMORRHAGE 5 0.0005
502 POLYURIA 4 0.0005
503 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
504 MANIA 8 0.0005
505 CHOLANGITIS 3 0.0005
506 OLIGURIA 3 0.0005
507 VENTRICULAR EXTRASYSTOLES 5 0.0005
508 INTERSTITIAL LUNG DISEASE 23 0.0005
509 SENSATION OF FOREIGN BODY 4 0.0005
510 MUSCLE ATROPHY 6 0.0005
511 HEPATIC CYTOLYSIS 6 0.0005
512 ABSCESS LIMB 2 0.0005
513 POST PROCEDURAL COMPLICATION 9 0.0005
514 LOWER LIMB FRACTURE 9 0.0005
515 BODY HEIGHT DECREASED 5 0.0005
516 C-REACTIVE PROTEIN INCREASED 17 0.0005
517 PSEUDOMONAS INFECTION 4 0.0005
518 PULMONARY EMBOLISM 44 0.0005
519 ECONOMIC PROBLEM 7 0.0005
520 HEPATITIS ACUTE 3 0.0005
521 KIDNEY INFECTION 9 0.0005
522 OFF LABEL USE 401 0.0005
523 ANHEDONIA 12 0.0005
524 EOSINOPHILIA 8 0.0005
525 HYPOKALAEMIA 21 0.0005
526 UPPER LIMB FRACTURE 9 0.0005
527 CEREBRAL INFARCTION 11 0.0004
528 THERAPY INTERRUPTED 32 0.0004
529 QUALITY OF LIFE DECREASED 6 0.0004
530 PULMONARY OEDEMA 20 0.0004
531 TREATMENT FAILURE 37 0.0004
532 URINARY TRACT INFECTION 76 0.0004
533 PLEURAL EFFUSION 27 0.0004
534 RASH PRURITIC 24 0.0004
535 ULCER 7 0.0004
536 SHOCK 10 0.0004
537 DRUG INTOLERANCE 42 0.0004
538 GASTRIC HAEMORRHAGE 5 0.0004
539 VOMITING 204 0.0004
540 LARGE INTESTINE POLYP 3 0.0004
541 PERICARDIAL EFFUSION 10 0.0004
542 DELIRIUM 15 0.0004
543 POST PROCEDURAL HAEMORRHAGE 5 0.0004
544 RENAL DISORDER 20 0.0004
545 DEFAECATION URGENCY 3 0.0004
546 SPLENOMEGALY 5 0.0004
547 HYPONATRAEMIA 24 0.0004
548 PAPULE 3 0.0004
549 COVID-19 PNEUMONIA 5 0.0004
550 DRUG LEVEL INCREASED 7 0.0004
551 FOOT FRACTURE 8 0.0004
552 THROMBOCYTOPENIA 47 0.0004
553 LEUKOPENIA 21 0.0004
554 BLOOD PRESSURE FLUCTUATION 10 0.0004
555 RESPIRATORY FAILURE 30 0.0004
556 CIRCULATORY COLLAPSE 7 0.0004
557 HAEMORRHOIDS 8 0.0004
558 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
559 BLINDNESS TRANSIENT 3 0.0004
560 THERAPY CHANGE 4 0.0004
561 CARDIOMEGALY 5 0.0004
562 LIGAMENT SPRAIN 4 0.0004
563 PHARYNGITIS 5 0.0004
564 DECREASED APPETITE 93 0.0004
565 AORTIC ANEURYSM 3 0.0004
566 TROPONIN INCREASED 3 0.0004
567 DEMENTIA 11 0.0004
568 AMMONIA INCREASED 2 0.0004
569 LIPASE INCREASED 3 0.0004
570 PROCEDURAL COMPLICATION 3 0.0004
571 ATRIAL FIBRILLATION 38 0.0004
572 HAEMOGLOBIN DECREASED 40 0.0004
573 DISEASE PROGRESSION 46 0.0004
574 LEUKOCYTOSIS 7 0.0004
575 POOR VENOUS ACCESS 4 0.0004
576 HAEMATOMA 10 0.0004
577 APNOEA 3 0.0004
578 HAEMORRHAGIC STROKE 3 0.0004
579 HYPERTENSION 81 0.0004
580 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
581 AGRANULOCYTOSIS 7 0.0004
582 ANAEMIA 71 0.0004
583 TACHYCARDIA 33 0.0004
584 THROAT TIGHTNESS 10 0.0004
585 SKIN LACERATION 4 0.0004
586 ASPHYXIA 3 0.0004
587 AKATHISIA 5 0.0004
588 HYPERAESTHESIA 3 0.0004
589 CHOLESTASIS 7 0.0004
590 ASTHENOPIA 2 0.0004
591 LIVE BIRTH 3 0.0004
592 SKIN INFECTION 4 0.0004
593 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
594 LYMPHOPENIA 5 0.0004
595 DERMATITIS CONTACT 4 0.0004
596 BLOOD MAGNESIUM DECREASED 3 0.0003
597 BLOOD PRESSURE DECREASED 23 0.0003
598 DYSARTHRIA 13 0.0003
599 ORTHOSTATIC HYPOTENSION 6 0.0003
600 CAESAREAN SECTION 4 0.0003
601 GROIN PAIN 3 0.0003
602 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
603 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
604 PULMONARY HYPERTENSION 7 0.0003
605 LOSS OF CONSCIOUSNESS 43 0.0003
606 CEREBRAL HAEMORRHAGE 12 0.0003
607 WRIST FRACTURE 4 0.0003
608 CONVULSION 19 0.0003
609 MOUTH ULCERATION 7 0.0003
610 HALLUCINATION 25 0.0003
611 HERPES ZOSTER 19 0.0003
612 DEHYDRATION 44 0.0003
613 SKIN LESION 9 0.0003
614 EPILEPSY 10 0.0003
615 IRON DEFICIENCY ANAEMIA 3 0.0003
616 CARDIAC FAILURE CONGESTIVE 26 0.0003
617 FEMUR FRACTURE 10 0.0003
618 DELUSION 5 0.0003
619 BACTERIAL INFECTION 6 0.0003
620 APPENDICITIS 3 0.0003
621 DIARRHOEA HAEMORRHAGIC 3 0.0003
622 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
623 PNEUMONIA ASPIRATION 8 0.0003
624 DYSPNOEA EXERTIONAL 12 0.0003
625 CYANOSIS 5 0.0003
626 COLITIS 12 0.0003
627 ANGIOEDEMA 14 0.0003
628 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
629 PNEUMOTHORAX 5 0.0003
630 HYPOPHAGIA 8 0.0003
631 HYPERCHOLESTEROLAEMIA 3 0.0003
632 ATELECTASIS 3 0.0003
633 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
634 CONFUSIONAL STATE 50 0.0003
635 DYSTONIA 6 0.0003
636 HOSPICE CARE 3 0.0003
637 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
638 ADVERSE REACTION 4 0.0003
639 HEPATIC FAILURE 9 0.0003
640 JAUNDICE 8 0.0003
641 FACE OEDEMA 5 0.0003
642 HYPOTHERMIA 3 0.0003
643 DRUG INTERACTION 47 0.0003
644 TASTE DISORDER 6 0.0003
645 BONE MARROW FAILURE 6 0.0003
646 CEREBROVASCULAR ACCIDENT 50 0.0003
647 LIMB INJURY 8 0.0003
648 MOTOR DYSFUNCTION 3 0.0003
649 LIVER DISORDER 13 0.0003
650 THERAPY CESSATION 15 0.0003
651 DIARRHOEA 188 0.0003
652 NAUSEA 229 0.0003
653 MULTI-ORGAN FAILURE 5 0.0003
654 OEDEMA PERIPHERAL 35 0.0003
655 SPEECH DISORDER 15 0.0003
656 CARPAL TUNNEL SYNDROME 4 0.0003
657 DEVICE OCCLUSION 4 0.0003
658 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
659 INCONTINENCE 3 0.0003
660 JOINT DISLOCATION 3 0.0003
661 DRUG INEFFECTIVE 374 0.0003
662 RENAL PAIN 3 0.0003
663 BRADYCARDIA 15 0.0003
664 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
665 JOINT INJURY 6 0.0003
666 SUBDURAL HAEMATOMA 4 0.0003
667 GOUT 5 0.0003
668 MOBILITY DECREASED 20 0.0003
669 ABDOMINAL PAIN LOWER 7 0.0003
670 HAEMATEMESIS 7 0.0003
671 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
672 PRODUCT PRESCRIBING ISSUE 6 0.0003
673 OESOPHAGITIS 3 0.0003
674 HYPERGLYCAEMIA 10 0.0003
675 BONE DISORDER 5 0.0003
676 CONDITION AGGRAVATED 83 0.0003
677 SURGERY 16 0.0003
678 ANAPHYLACTIC SHOCK 7 0.0003
679 PNEUMONIA 87 0.0003
680 HEPATIC STEATOSIS 5 0.0003
681 HEPATIC CIRRHOSIS 5 0.0003
682 MYOCARDIAL INFARCTION 46 0.0003
683 PRODUCT AVAILABILITY ISSUE 6 0.0003
684 PROTEINURIA 5 0.0003
685 INFECTION 38 0.0003
686 DIABETES MELLITUS 20 0.0003
687 INSURANCE ISSUE 4 0.0003
688 NEOPLASM 3 0.0003
689 PAIN OF SKIN 7 0.0003
690 RENAL FAILURE ACUTE 11 0.0003
691 ATRIOVENTRICULAR BLOCK 2 0.0003
692 FALL 86 0.0003
693 VASCULITIS 3 0.0003
694 NERVOUS SYSTEM DISORDER 8 0.0003
695 BALANCE DISORDER 22 0.0003
696 PRODUCT USE COMPLAINT 4 0.0003
697 RESPIRATORY DISTRESS 7 0.0003
698 BLOOD IRON DECREASED 3 0.0003
699 BACTERAEMIA 3 0.0003
700 CHOLECYSTITIS 3 0.0003
701 ABSCESS 4 0.0003
702 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
703 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
704 OXYGEN SATURATION DECREASED 14 0.0002
705 MUSCULOSKELETAL PAIN 13 0.0002
706 LOCALISED INFECTION 6 0.0002
707 THERAPEUTIC RESPONSE DECREASED 15 0.0002
708 LIVER INJURY 6 0.0002
709 SMALL INTESTINAL OBSTRUCTION 3 0.0002
710 OSTEONECROSIS 8 0.0002
711 BACK PAIN 56 0.0002
712 VIRAL INFECTION 8 0.0002
713 COAGULOPATHY 4 0.0002
714 NEOPLASM MALIGNANT 16 0.0002
715 BONE PAIN 14 0.0002
716 CELLULITIS 12 0.0002
717 MUSCULAR WEAKNESS 27 0.0002
718 LABORATORY TEST ABNORMAL 7 0.0002
719 INTRAOCULAR PRESSURE INCREASED 3 0.0002
720 SCAR 4 0.0002
721 MUSCULOSKELETAL DISCOMFORT 4 0.0002
722 SKIN CANCER 5 0.0002
723 PYREXIA 80 0.0002
724 NODULE 3 0.0002
725 BLOOD GLUCOSE DECREASED 11 0.0002
726 PARAESTHESIA 36 0.0002
727 PULMONARY CONGESTION 3 0.0002
728 SARS-COV-2 TEST POSITIVE 3 0.0002
729 LETHARGY 13 0.0002
730 TOXICITY TO VARIOUS AGENTS 38 0.0002
731 TOOTH DISORDER 5 0.0002
732 PANCREATITIS ACUTE 5 0.0002
733 OEDEMA 12 0.0002
734 HEAD INJURY 7 0.0002
735 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
736 GINGIVAL BLEEDING 3 0.0002
737 WEIGHT DECREASED 61 0.0002
738 RESPIRATORY ARREST 6 0.0002
739 COVID-19 38 0.0002
740 CONSTIPATION 47 0.0002
741 DEEP VEIN THROMBOSIS 14 0.0002
742 BLOOD TEST ABNORMAL 3 0.0002
743 PALPITATIONS 25 0.0002
744 IMPAIRED HEALING 7 0.0002
745 INFLAMMATION 11 0.0002
746 INTESTINAL OBSTRUCTION 8 0.0002
747 INTENTIONAL DOSE OMISSION 6 0.0002
748 MUSCULOSKELETAL DISORDER 4 0.0002
749 PRODUCT PRESCRIBING ERROR 5 0.0002
750 PRODUCTIVE COUGH 10 0.0002
751 DIZZINESS 104 0.0002
752 PARAESTHESIA ORAL 3 0.0002
753 HYPERTHYROIDISM 3 0.0002
754 HERNIA 4 0.0002
755 ABDOMINAL PAIN 48 0.0002
756 ORAL HERPES 4 0.0002
757 LUNG DISORDER 10 0.0002
758 PSYCHOTIC DISORDER 6 0.0002
759 BLOOD PRESSURE INCREASED 31 0.0002
760 OSTEONECROSIS OF JAW 5 0.0002
761 MUSCLE SPASMS 37 0.0002
762 EPISTAXIS 15 0.0002
763 DYSPHAGIA 19 0.0002
764 SYNCOPE 20 0.0002
765 SWELLING FACE 13 0.0002
766 ASTHENIA 75 0.0002
767 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
768 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
769 DYSPNOEA 110 0.0002
770 EJECTION FRACTION DECREASED 3 0.0002
771 TOOTH LOSS 4 0.0002
772 CARDIAC DISORDER 18 0.0002
773 RESPIRATORY TRACT INFECTION 5 0.0002
774 DEAFNESS 5 0.0002
775 DERMATITIS 4 0.0002
776 ABDOMINAL DISCOMFORT 32 0.0002
777 AGITATION 14 0.0002
778 SICKLE CELL ANAEMIA WITH CRISIS 3 0.0002
779 DISEASE RECURRENCE 9 0.0002
780 SCIATICA 3 0.0002
781 IMPAIRED WORK ABILITY 4 0.0002
782 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
783 FEAR 5 0.0002
784 ABDOMINAL PAIN UPPER 38 0.0002
785 CHEST PAIN 34 0.0002
786 DYSPEPSIA 18 0.0002
787 MULTIPLE FRACTURES 3 0.0002
788 MYALGIA 31 0.0002
789 ABDOMINAL DISTENSION 19 0.0002
790 HAEMATOCHEZIA 10 0.0002
791 ILL-DEFINED DISORDER 11 0.0002
792 ANAPHYLACTIC REACTION 10 0.0002
793 STEVENS-JOHNSON SYNDROME 4 0.0002
794 COLITIS ULCERATIVE 8 0.0002
795 NECK PAIN 10 0.0002
796 ORAL PAIN 4 0.0002
797 COUGH 50 0.0002
798 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
799 TARDIVE DYSKINESIA 5 0.0002
800 FLUID RETENTION 9 0.0002
801 DISORIENTATION 7 0.0002
802 CHEST DISCOMFORT 18 0.0002
803 HAEMATURIA 6 0.0002
804 RED BLOOD CELL COUNT DECREASED 5 0.0002
805 TREMOR 29 0.0002
806 EMOTIONAL DISTRESS 21 0.0002
807 BLINDNESS 7 0.0002
808 HEART RATE DECREASED 6 0.0002
809 METASTASES TO LIVER 3 0.0002
810 PRODUCT DOSE OMISSION ISSUE 50 0.0002
811 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
812 LYMPHOCYTE COUNT DECREASED 3 0.0002
813 HEAD DISCOMFORT 3 0.0002
814 ANXIETY 48 0.0002
815 ISCHAEMIC STROKE 3 0.0002
816 THIRST 3 0.0002
817 RHABDOMYOLYSIS 7 0.0002
818 RESPIRATORY DISORDER 5 0.0002
819 BLOOD POTASSIUM DECREASED 5 0.0002
820 CONTUSION 16 0.0002
821 ADRENAL INSUFFICIENCY 2 0.0002
822 DYSURIA 6 0.0002
823 CHILLS 19 0.0002
824 THROMBOSIS 13 0.0002
825 ERYTHEMA 33 0.0002
826 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
827 UNEVALUABLE EVENT 12 0.0002
828 BLOOD URINE PRESENT 3 0.0002
829 GASTRIC CANCER 4 0.0002
830 CYSTITIS 5 0.0002
831 SEIZURE 18 0.0002
832 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
833 RHINORRHOEA 10 0.0002
834 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
835 ECZEMA 8 0.0002
836 SEDATION 4 0.0002
837 INFLUENZA 17 0.0002
838 ABNORMAL BEHAVIOUR 6 0.0002
839 HAEMATOCRIT DECREASED 3 0.0002
840 BLOOD PRESSURE ABNORMAL 3 0.0002
841 SKIN DISORDER 5 0.0001
842 COGNITIVE DISORDER 7 0.0001
843 GAIT INABILITY 5 0.0001
844 SOMNOLENCE 30 0.0001
845 FULL BLOOD COUNT DECREASED 3 0.0001
846 HEADACHE 93 0.0001
847 DISCOMFORT 9 0.0001
848 MOOD ALTERED 4 0.0001
849 ACUTE HEPATIC FAILURE 2 0.0001
850 GASTRIC DISORDER 5 0.0001
851 PROCEDURAL PAIN 4 0.0001
852 MEDICATION ERROR 8 0.0001
853 HAEMOPTYSIS 4 0.0001
854 HALLUCINATION, VISUAL 3 0.0001
855 HEART RATE INCREASED 14 0.0001
856 ADVERSE EVENT 13 0.0001
857 EATING DISORDER 3 0.0001
858 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
859 MYELOSUPPRESSION 5 0.0001
860 PRURITUS GENERALISED 3 0.0001
861 PAIN 85 0.0001
862 FAECES DISCOLOURED 3 0.0001
863 LIVER FUNCTION TEST ABNORMAL 4 0.0001
864 APATHY 2 0.0001
865 DYSSTASIA 4 0.0001
866 DYSPHONIA 8 0.0001
867 HEPATIC FUNCTION ABNORMAL 5 0.0001
868 HAEMORRHAGE 14 0.0001
869 RASH PAPULAR 3 0.0001
870 ADVERSE DRUG REACTION 12 0.0001
871 HEART RATE IRREGULAR 3 0.0001
872 MUSCLE TWITCHING 3 0.0001
873 LIMB DISCOMFORT 4 0.0001
874 ANKLE FRACTURE 2 0.0001
875 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
876 SWOLLEN TONGUE 4 0.0001
877 SLEEP DISORDER 9 0.0001
878 ARTHRITIS 10 0.0001
879 OCULAR HYPERAEMIA 6 0.0001
880 ILLNESS 13 0.0001
881 COMA 6 0.0001
882 RENAL CANCER 6 0.0001
883 HYPOTHYROIDISM 4 0.0001
884 BLISTER 7 0.0001
885 NIGHT SWEATS 4 0.0001
886 PRESYNCOPE 3 0.0001
887 NEURALGIA 3 0.0001
888 PERIPHERAL SWELLING 19 0.0001
889 DEPRESSION 28 0.0001
890 DYSKINESIA 5 0.0001
891 PRODUCT SUBSTITUTION ISSUE 7 0.0001
892 ABASIA 3 0.0001
893 HYPOAESTHESIA 18 0.0001
894 POLLAKIURIA 5 0.0001
895 AGGRESSION 6 0.0001
896 ROAD TRAFFIC ACCIDENT 5 0.0001
897 TYPE 2 DIABETES MELLITUS 4 0.0001
898 OSTEOARTHRITIS 5 0.0001
899 ERECTILE DYSFUNCTION 3 0.0001
900 DIPLOPIA 3 0.0001
901 MENTAL DISORDER 5 0.0001
902 VERTIGO 7 0.0001
903 INJURY 8 0.0001
904 DEPRESSED MOOD 6 0.0001
905 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
906 DISTURBANCE IN ATTENTION 6 0.0001
907 GAIT DISTURBANCE 21 0.0001
908 PAIN IN EXTREMITY 32 0.0001
909 NASOPHARYNGITIS 20 0.0001
910 BRONCHITIS 8 0.0001
911 PRODUCT USE ISSUE 20 0.0001
912 ASTHMA 12 0.0001
913 PAIN IN JAW 3 0.0001
914 ARTHRALGIA 44 0.0001
915 FEBRILE NEUTROPENIA 7 0.0001
916 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
917 EYE IRRITATION 6 0.0001
918 PLASMA CELL MYELOMA 4 0.0001
919 PRURITUS 39 0.0001
920 FATIGUE 79 0.0001
921 INSOMNIA 27 0.0001
922 APHASIA 3 0.0001
923 DRY MOUTH 8 0.0001
924 DRUG ADMINISTRATION ERROR 3 0.0001
925 LUNG NEOPLASM MALIGNANT 4 0.0001
926 NERVOUSNESS 5 0.0001
927 DRUG-INDUCED LIVER INJURY 3 0.0001
928 DYSGEUSIA 7 0.0001
929 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
930 HOT FLUSH 7 0.0001
931 OVERDOSE 20 0.0001
932 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
933 HYPERSENSITIVITY 17 0.0001
934 EYE DISORDER 3 0.0001
935 VISUAL ACUITY REDUCED 3 0.0001
936 FUNGAL INFECTION 3 0.0001
937 ARTHROPATHY 5 0.0001
938 URINARY RETENTION 3 0.0001
939 WEIGHT INCREASED 20 0.0001
940 EYE PRURITUS 3 0.0001
941 MALAISE 39 0.0001
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
943 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
944 VISUAL IMPAIRMENT 11 0.0001
945 NEOPLASM PROGRESSION 3 0.0001
946 SWELLING 8 0.0001
947 HYPERHIDROSIS 11 0.0001
948 NASAL CONGESTION 5 0.0001
949 PLATELET COUNT DECREASED 9 0.0001
950 WHEEZING 5 0.0001
951 NEUROPATHY PERIPHERAL 8 0.0001
952 CATARACT 5 0.0001
953 JOINT SWELLING 10 0.0001
954 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
955 VISION BLURRED 11 0.0001
956 SUICIDAL IDEATION 7 0.0001
957 FEELING ABNORMAL 18 0.0001
958 RASH 32 0.0001
959 MEMORY IMPAIRMENT 10 0.0001
960 DEVICE DISLOCATION 3 0.0001
961 BLOOD GLUCOSE INCREASED 13 0.0001
962 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
963 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
964 NEUTROPENIA 9 0.0001
965 STOMATITIS 4 0.0001
966 TINNITUS 3 0.0001
967 SKIN DISCOLOURATION 3 0.0001
968 MIGRAINE 6 0.0001
969 AMNESIA 4 0.0001
970 INCORRECT DOSE ADMINISTERED 14 0.0001
971 INFUSION RELATED REACTION 4 0.0001
972 SKIN EXFOLIATION 5 0.0001
973 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
974 BURNING SENSATION 4 0.0001
975 DERMATITIS ATOPIC 3 0.0001
976 UNDERDOSE 4 0.0001
977 ACCIDENTAL OVERDOSE 2 0.0001
978 OROPHARYNGEAL PAIN 5 0.0001
979 FLATULENCE 3 0.0001
980 DRY SKIN 7 0.0001
981 FEELING HOT 3 0.0000
982 INTENTIONAL PRODUCT MISUSE 4 0.0000
983 NO ADVERSE EVENT 8 0.0000
984 HEPATIC ENZYME INCREASED 3 0.0000
985 BREAST CANCER 4 0.0000
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
987 URTICARIA 7 0.0000
988 FLUSHING 4 0.0000
989 PRODUCT QUALITY ISSUE 5 0.0000
990 SINUSITIS 3 0.0000
991 ALOPECIA 5 0.0000